Howard Edington, MD

Dr. Howard D. Edington brings over three decades of surgical expertise to the forefront of oncology, specializing in the intricate management of melanoma and soft tissue malignancies. As the director of both the Cutaneous Oncology Program and the Melanoma and Skin Cancer Center at AHN, he has cultivated a reputation for innovation, particularly in the use of oncolytic virus therapy for treating non-resectable melanomas.

His academic journey began with a medical degree from Temple University School of Medicine, followed by rigorous training through internships and residencies at UPMC. Dr. Edington further honed his skills during a fellowship at the National Cancer Institute, positioning him at the cutting edge of surgical oncology.

Patients benefit from his comprehensive approach, which includes wide local excision surgeries and advanced techniques for lymph node evaluation. Driven by a commitment to improving patient outcomes, Dr. Edington's work continues to redefine the landscape of skin cancer treatment.